Will Exopharm (ASX:EX1) Spend Its Cash Wisely?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Over the last 7 days, the Biotech industry has dropped 2.2%, driven by a pullback from CSL of 2.2%. Meanwhile, Aroa Biosurgery actually outperformed within the industry, gaining 5.8% in the last week. Overall the industry is down 9.9% in 12 months. As for the next few years, earnings are expected to grow by 16% per annum.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE |
---|---|---|---|---|
Sat, 28 May 2022 | AU$136.2b | AU$15.3b | AU$2.7b | 35.5x |
Mon, 25 Apr 2022 | AU$137.7b | AU$14.8b | AU$2.7b | 38x |
Wed, 23 Mar 2022 | AU$135.6b | AU$14.5b | AU$2.6b | 40x |
Fri, 18 Feb 2022 | AU$143.0b | AU$15.0b | AU$2.7b | 41.2x |
Sun, 16 Jan 2022 | AU$143.5b | AU$14.5b | AU$2.8b | 40.2x |
Tue, 14 Dec 2021 | AU$148.0b | AU$14.6b | AU$2.8b | 40.9x |
Thu, 11 Nov 2021 | AU$156.4b | AU$14.2b | AU$2.7b | 44.4x |
Sat, 09 Oct 2021 | AU$144.5b | AU$14.3b | AU$2.7b | 40.8x |
Mon, 06 Sep 2021 | AU$151.7b | AU$14.0b | AU$2.6b | 44x |
Wed, 04 Aug 2021 | AU$143.8b | AU$14.0b | AU$2.6b | 42x |
Sat, 08 May 2021 | AU$132.5b | AU$13.5b | AU$2.8b | 37.3x |
Tue, 09 Feb 2021 | AU$132.3b | AU$13.1b | AU$3.0b | 35.8x |
Mon, 02 Nov 2020 | AU$138.5b | AU$13.5b | AU$2.9b | 31.2x |
Thu, 06 Aug 2020 | AU$130.3b | AU$13.5b | AU$2.7b | 40.3x |
Sun, 10 May 2020 | AU$146.8b | AU$14.9b | AU$3.0b | 42x |
Sat, 01 Feb 2020 | AU$149.3b | AU$12.9b | AU$2.5b | 49.6x |
Tue, 05 Nov 2019 | AU$122.7b | AU$13.1b | AU$2.6b | 65.6x |
Fri, 09 Aug 2019 | AU$109.0b | AU$12.3b | AU$2.4b | 62.9x |
67.4x
How does Australian Biotech compare with similar industries?
AU Market | -1.30% | |
Healthcare | -1.59% | |
Biotech | -2.20% | |
Biotech | -2.20% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ARX Aroa Biosurgery | AU$0.82 | 5.8% +AU$15.4m | -32.0% | PS7.8x | |
PAR Paradigm Biopharmaceuticals | AU$1.21 | 3.0% +AU$8.0m | -46.9% | PS4303.6x | |
PTX Prescient Therapeutics | AU$0.17 | 6.5% +AU$6.5m | 50.0% | PS78.2x | |
CYP Cynata Therapeutics | AU$0.40 | 12.7% +AU$6.4m | -32.2% | PS6.8x | |
PYC PYC Therapeutics | AU$0.073 | 2.8% +AU$6.4m | -54.4% | PS25.6x |